Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
BACKGROUND: Low-dose aspirin is of definite and substantial net benefit for many people who already have occlusive vascular disease. We have assessed the benefits and risks in primary prevention. METHODS: We undertook meta-analyses of serious vascular events (myocardial infarction, stroke, or vascul...
Հիմնական հեղինակներ: | Baigent, C, Blackwell, L, Collins, R, Emberson, J, Godwin, J, Peto, R, Buring, J, Hennekens, C, Kearney, P, Meade, T, Patrono, C, Roncaglioni, M, Zanchetti, A |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
Elsevier
2009
|
Նմանատիպ նյութեր
-
Efficacy of aspirin in people with diabetes: an individual participant data meta-analysis of 26 randomised trials
: Wong, C, և այլն
Հրապարակվել է: (2014) -
Aspirin in the primary prevention of vascular disease Reply
: Baigent, C, և այլն
Հրապարակվել է: (2009) -
Aspirin in the primary prevention of vascular disease Reply
: Baigent, C, և այլն
Հրապարակվել է: (2009) -
Aspirin and stroke.
: Buring, J, և այլն
Հրապարակվել է: (1990) -
Aspirin in ischemic heart disease.
: Hennekens, C, և այլն
Հրապարակվել է: (1992)